M42’s ICLDC in Abu Dhabi leads the way in helping international chronic kidney disease patients book world-class dialysis treatment on bookdialysis.com
Imperial College London Diabetes Centre (ICLDC), part of the M42 group, has become the first centre in Abu Dhabi to partner with bookdialysis, the leading online booking engine for holiday dialysis patients. ICLDC now joins a coveted network of top-tier clinics in more than 50 countries listed on the free booking platform, offering global travelers with chronic kidney disease (CKD) peace of mind when traveling to the UAE for leisure or work.
Marking a key milestone in premium patient-centric care, ICLDC’s world-class dialysis services and personalised therapy options will be seamlessly integrated into bookdialysis’s user-friendly platform, effective immediately.
International travelers coming to the UAE and the region can now access ICLDC’s hemodialysis and hemodiafiltration services online and book their required treatments in real-time, at no cost to the user. Caregivers at ICLDC can also assist dialysis patients in booking holiday treatments through bookdialysis while traveling abroad, empowering them to take control of their own health. This marks a significant step forward in its holistic approach to the treatment of diabetes and related conditions.
For the past 18 years, ICLDC has been at the forefront of diabetes and chronic kidney disease management. Renowned for its commitment to personalised care, ICLDC's team of specialists delivers tailored therapy options, resulting in significant improvements in patient health. ICLDC’s low-clearance kidney clinics demonstrate its dedication to meeting patients’ diverse needs, ensuring access to life-sustaining treatment for individuals with end-stage renal disease.
Dr. Mai Al Jaber, Chief Executive Officer of Imperial College London Diabetes Centre, said, “Imperial College London Diabetes Centre's partnership with bookdialysis epitomises our shared commitment to continually improve the quality of life for our patients. Approximately 10 percent of the global population is affected by this disease, amounting to over 800 million people worldwide. By harnessing the transformative power of technology, we are redefining the dialysis travel experience, ensuring that patients who come to the UAE and Abu Dhabi receive unparalleled care and support regardless of where they come from. This collaboration opens up so many opportunities for individuals battling chronic kidney disease, promising enhanced quality of life and limitless options for exploration.”
Bookdialysis was established in 2017 and over the last seven years has emerged as the leading online booking engine for holiday dialysis patients worldwide, and a trusted partner of Kidney Patient Associations and the broader CKD community. Boasting a network of over 800 certified dialysis clinics globally and available in nine languages, the platform enables chronic patient mobility and treatment continuity through its innovative digital platform and integrated solutions. With existing partnerships across four continents, bookdialysis empowers patients to embark on transformative journeys while receiving uninterrupted care.
Evgenia Kafousi, Operations Director for bookdialysis, said, “We are delighted to partner with M42’s Imperial College London Diabetes Centre to enable travelers in Abu Dhabi to receive world-class kidney care. Travel for dialysis patients can be complex, but with bookdialysis it doesn’t need to be that way. With our user-friendly platform, it is our mission to offer our users the freedom to travel with the confidence that their treatment continuity is guaranteed while they are away from home, giving them the opportunity to explore the world as anyone else who doesn’t require frequent, life-sustaining treatment. Together with M42 and Imperial College London Diabetes Centre, we are breaking down barriers to patient mobility, empowering individuals in Abu Dhabi and beyond to access world-class kidney care seamlessly.”
With over 75 diabetes and endocrine consultants operating in the UAE, ICLDC has significantly impacted the health landscape of the UAE. It has achieved remarkable patient outcomes, including a substantial reduction in HbA1c levels from 9.5 percent to 7.2 percent over the past decade. To date, 57 percent of ICLDC’s patients have an HbA1c result of less than seven percent, outperforming the international benchmark of 38 percent.
The announcement closely follows M42’s International Patient Services being announced as the first in the Middle East to receive Global Healthcare Accreditation Certification. M42's remarkable 91 percent score signals unmatched patient care standards within the region positioning the UAE as a premier medical destination. M42’s priority is people, not just patients; health, not just healthcare; and prevention, not just treatment; and the certification strengthens the UAE's position as a premier destination for medical tourism.
The bookdialysis app is available for download via the App Store and Google Play. Dialysis travelers and their families are invited to download it and start exploring new worlds.
